141 completed, 33 unknown, 21 terminated, 9 recruiting. 215 Phase 3, 27 Phase 2.
Follow Atorvastatin: new trials by email Literature Review of Atorvastatin trials Research Report on Atorvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque Alirocumab, Placebo, Atorvastatin - Carotid Stenosis | Phase 3 | Not yet recruiting | Middle East North Africa Stroke and Interventional Neurotherapies Organization | 280 | 2027-07-01 | 2026-05-14 |
| A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events Bempedoic acid, Ezetimibe, Rosuvastatin - Coronary Atherosclerosis, Mixed Dyslipidemia | Phase 3 | Not yet recruiting | Daiichi Sankyo | 103 | 2026-09-30 | 2026-09-29 |
| A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID Maraviroc (MVC), Atorvastatin, 10mg, 20mg, 40mg, Placebo, Maraviroc - Long COVID | Phase 2 / Phase 3 | Not yet recruiting | HealthBio, Inc. | 252 | 2026-07-15 | 2026-06-18 |
| A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI) acetylsalicyclic acid (ASA), Clopidogrel, Rosuvastatin - Covert Brain Infarction | Phase 3 | Recruiting | Aarhus University Hospital | 1652 | 2025-11-26 | 2025-12-04 |
| Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients Atorvastatin, Metformin, Placebo - Schizophrenia | Phase 3 | Recruiting | Central South University | 400 | 2025-07-01 | 2026-08-03 |
| Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin), Colchicine 0.5 mg, Usual Care Group - Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD) | Phase 3 | Recruiting | Hospital do Coracao | 7713 | 2025-06-12 | 2026-01-22 |
| Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke PCSK9 inhibitors combined with atorvastatin/rosuvastatin, Atorvastatin/Rosuvastatin - Acute Ischemic Stroke | Phase 2 / Phase 3 | Completed | Xiang Luo | 429 | 2024-11-29 | 2026-06-09 |
| Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR) Atorvastatin - Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal | Phase 3 | Withdrawn | The George Institute | 2024-09-01 | 2026-10-05 | |
| Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke Atorvastatin 40 Mg Oral Tablet, Rosuvastatin 20mg, Clopidogrel 75 Mg Oral Tablet - Ischemic Stroke | Phase 3 | Recruiting | Kafrelsheikh University | 600 | 2024-04-10 | 2025-09-05 |
| Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke Atorvastatin 40mg, Rosuvastatin 20mg - Ischemic Stroke | Phase 3 | Recruiting | Kafrelsheikh University | 600 | 2024-04-10 | 2026-04-23 |
| A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study Atorvastatin 20mg, Placebo - Graves' Orbitopathy | Phase 3 | Not yet recruiting | University of Pisa | 102 | 2024-01-01 | 2023-03-15 |
| Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS) Alirocumab, Atorvastatin - Intracranial Atherosclerosis, Atherosclerotic Plaque | Phase 3 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 80 | 2023-12-30 | 2023-12-21 |
| A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo - Essential Hypertension, Primary Hypercholesterolemia | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 148 | 2023-07-13 | 2024-10-18 |
| Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS) Evolocumab, Atorvastatin - Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis | Phase 3 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 80 | 2023-04-15 | 2023-06-02 |
| Measuring Oncological Value of Exercise and Statin Guided physical exercise, Atorvastatin, Independent exercise - Prostate Cancer, Breast Cancer | Phase 3 | Recruiting | Tampere University Hospital | 240 | 2023-03-31 | 2025-06-27 |
| Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis Allopurinol 300 MG, Atorvastatin 20mg, Placebo - Cirrhosis, Hepatic Encephalopathy | Phase 2 / Phase 3 | Completed | Tanta University | 150 | 2022-11-15 | 2026-08-11 |
| Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg - Hypercholesterolemia, Dyslipidemia | Phase 3 | Completed | Daewon Pharmaceutical Co., Ltd. | 252 | 2022-08-17 | 2023-08-01 |
| Statin Impact on Hepatic Decompensation Atorvastatin 20mg, Placebo - Quality of Life, the Incidence of Whole Complications Resultant From Decompensated Liver | Phase 2 / Phase 3 | Completed | Tanta University | 100 | 2022-06-15 | 2026-09-14 |
| Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer Metabolic treatment - Cancer, Overall Survival | Phase 3 | Withdrawn | Health Clinics Limited | 2022-05-23 | 2022-07-18 | |
| Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment Aerobic exercise + Ginkgo Biloba Extract, Aerobic exercise + Calcined magnesia (placebo), Aerobic exercise + Atorvastatin - Human Immunodeficiency Virus | Phase 2 / Phase 3 | Completed | University of Guadalajara | 28 | 2022-05-01 | 2024-05-08 |
Showing 20 of 215. Sign in to see all of them.
Hypercholesterolemia (62) · Dyslipidemias (31) · Hyperlipidemias (31) · Coronary Artery Disease (12) · Atherosclerosis (10) · Coronary Disease (9) · Diabetes Mellitus, Type 2 (8) · Hyperlipoproteinemia Type II (8) · COVID-19 (7) · Cardiovascular Diseases (7) · Stroke (6) · Breast Neoplasms (5) · Ischemic Stroke (5) · Acute Coronary Syndrome (4) · Diabetes Mellitus (4)
Organon and Co (20) · Pfizer (15) · AstraZeneca (14) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (7) · Sanofi (7) · Abbott (6) · Amgen (6) · Takeda (5) · Government Dental College and Research Institute, Bangalore (4) · Brigham and Women's Hospital (3) · Kowa Research Europe (3) · Merck Sharp & Dohme LLC (3) · Regeneron Pharmaceuticals (3) · Aarhus University Hospital (2) · Boryung Pharmaceutical Co., Ltd (2)
United States (57) · Canada (33) · United Kingdom (18) · Germany (17) · Italy (17) · France (16) · South Korea (16) · Mexico (15) · Netherlands (15) · Spain (15) · Australia (14) · Czechia (14) · Denmark (14) · China (12) · South Africa (12)
Russell Esterline (7) · Andrew Selwyn, MD (2) · Clotilde Fuentes-Orozco, PhD (2) · Dragos Budinski, Med Dr. (2) · Subhash Banerjee, MD (2)
PMID 21518985, PMID 19029469, PMID 27777279, PMID 30183102, PMID 34298554, PMID 16731270, PMID 17407645, PMID 18783301, PMID 20167359, PMID 20228610, PMID 20645885, PMID 21613319, PMID 25431239, PMID 28964736, PMID 31867054, PMID 32791950, PMID 34515113, PMID 10190267, PMID 10650325, PMID 10859281, PMID 10919968, PMID 11277825, PMID 11326085, PMID 11529691, PMID 11729302, PMID 11834528, PMID 11895451, PMID 11975885, PMID 12034651, PMID 12213433, PMID 12417828, PMID 12421890, PMID 12430089, PMID 12485966, PMID 12686036, PMID 12719279, PMID 12730697, PMID 12829554, PMID 12867219, PMID 12908852, PMID 12972104, PMID 14607021, PMID 14666956, PMID 15007110, PMID 15007111, PMID 15207950, PMID 15331429, PMID 15389231, PMID 15478042, PMID 15553600
2017 (3), 2005 (2), 2008 (2), 2019 (2), 2025 (2), 2004 (1), 2009 (1), 2015 (1), 2016 (1), N01AR022265 (1), R01AG021570 (1), R01HL075771 (1)